(FM) Inmunología
Departamento académico
Yale School of Medicine
New Haven, Estados UnidosPublicaciones en colaboración con investigadores/as de Yale School of Medicine (25)
2024
-
Spatially resolved tissue imaging to analyze the tumor immune microenvironment: beyond cell-type densities
Journal for immunotherapy of cancer, Vol. 12, Núm. 5
2022
-
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
Journal for immunotherapy of cancer, Vol. 10, Núm. 3
2021
-
A burned-out cd8+ t-cell subset expands in the tumor microenvironment and curbs cancer immunotherapy
Cancer Discovery, Vol. 11, Núm. 7, pp. 1700-1715
-
Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL-8
Journal of Pathology, Vol. 255, Núm. 2, pp. 190-201
-
IL8, neutrophils, and NETs in a collusion against cancer immunity and immunotherapy
Clinical Cancer Research, Vol. 27, Núm. 9, pp. 2383-2393
2020
-
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity
Immunity, Vol. 52, Núm. 5, pp. 856-871.e8
-
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Nature Medicine, Vol. 26, Núm. 5, pp. 688-692
-
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
Nature Immunology, Vol. 21, Núm. 2, pp. 120-134
2019
-
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Nature Medicine, Vol. 25, Núm. 3, pp. 470-476
2018
-
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
Annals of Oncology, Vol. 29, Núm. 5, pp. 1312-1319
-
Immunodivergence in Metastatic Colorectal Cancer
Cancer Cell
-
Immunotherapy targeting 4-1BB: Mechanistic rationale, clinical results, and future strategies
Blood, Vol. 131, Núm. 1, pp. 49-57
-
Introducing a new series: Immunotherapy facts and hopes
Clinical Cancer Research
2017
-
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients
Annals of Oncology, Vol. 28, Núm. 8, pp. 1988-1995
-
Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer
Cancer Discovery, Vol. 7, Núm. 12, pp. 1420-1435
-
Interleukin-8 in cancer pathogenesis, treatment and follow-up
Cancer Treatment Reviews, Vol. 60, pp. 24-31
-
Predictors of responses to immune checkpoint blockade in advanced melanoma
Nature Communications, Vol. 8, Núm. 1
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
2016
-
Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming
Cancer Research, Vol. 76, Núm. 20, pp. 5994-6005
-
Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies
Annals of Oncology, Vol. 27, Núm. 7, pp. 1190-1198